Ipsen publishes its 2020 Universal Registration Document
Ipsen publishes its 2020 Universal Registration Document
This article or press release has no online content. Please download the associated documents for more information.
Ipsen publishes its 2020 Universal Registration Document
- 15 April 2021 - 1 mins read
This article or press release has no online content. Please download the associated documents for more information.
Related Press Releases
19 January 2024
7 mins read
TOXINS 2024: Results from Ipsen’s AboLiSh study demonstrate the significant clinical benefit of using injection guidance techniques when treating spasticity with abobotulinumtoxinA
14 November 2023
1 mins read
IPSEN – Buy-back programme – Art 5 of MAR – Week 45 – 2023
13 November 2023
11 mins read
Results from Ipsen’s ELATIVE® pivotal Phase III trial of elafibranor in PBC presented as late breaking data at AASLD congress and published in New England...
07 November 2023
1 mins read
IPSEN – Buy-back programme – Art 5 of MAR – Week 44 – 2023
03 October 2023
5 mins read
Ipsen updates on QM-1114 regulatory process
26 September 2023
1 mins read
IPSEN – Buy-back programme – Art 5 of MAR – Week 38 – 2023
04 September 2023
5 mins read
Ipsen nominates Pascal Touchon to its Board of Directors as new independent director
21 August 2023
15 mins read
Exelixis and Ipsen Announce Positive Results from Phase 3 CONTACT-02 Pivotal Trial Evaluating Cabozantinib in Combination with Atezolizumab in Metastatic Castration-Resistant Prostate Cancer
18 July 2023
1 mins read
IPSEN – Buy-back programme – Art 5 of MAR – Week 28 – 2023
01 June 2023
2 mins read